Public health & disease

From disease eradication efforts to advances in vaccination and maternal health, this archive tracks real progress in public health. Stories here focus on what’s working — policies, interventions, and research that are improving and extending lives around the world.

Injecting vaccine, for article on India HPV vaccine

Indian company develops country’s first HPV vaccine

CERVAVAC, India’s first homegrown cervical cancer vaccine, is priced at just $2.50 to $5.00 per dose — a fraction of what HPV vaccines have cost in wealthy countries for nearly two decades. Developed by the Serum Institute of India, it protects against the HPV strains responsible for the majority of cervical cancers worldwide, and the company aims to produce around 200 million doses in its first two years. Cervical cancer is almost entirely preventable, yet it still kills hundreds of thousands of women each year, mostly in lower-income countries where vaccines have been priced out of reach. An affordable, locally made option doesn’t just change the math for India — it points toward a future where health tools belong to the people who need them most.

Female scientist pipetting colored chemicals into a tube, for article on CAR T-cell therapy

Scientists hail autoimmune disease therapy breakthrough

Lupus remission in all five patients — that’s the striking result from a small German trial using CAR T-cell therapy, a treatment originally developed for blood cancers. Doctors collected each patient’s own T-cells, reprogrammed them to clear out the malfunctioning B cells driving the disease, and reinfused them. Months later, the patients’ immune systems had essentially rebooted: new B cells grew back, but they no longer attacked the body. None have needed lupus medication since. The lead researcher believes the same approach could help people with rheumatoid arthritis, multiple sclerosis, and other autoimmune conditions — opening a hopeful new chapter for millions worldwide who have long managed their illness without ever truly being free of it.

Black baby boy, for article on mother-to-child HIV transmission

Botswana reduces mother-baby HIV transmission rates from 40% to below 1% since 1999

Mother-to-child HIV transmission in Botswana has plummeted from 40% in 1999 to below 1% today, with seven health districts recording zero cases in 2021. The country built its success on three simple pillars — free testing, free antiretroviral treatment, and community health workers who visit pregnant women at home to walk them through the process. Nearly every pregnant woman with HIV now receives treatment, up from just 27% two decades ago. In December 2021, Botswana became the first high-burden country to earn the WHO’s silver tier recognition for this work. It’s a powerful blueprint for the rest of sub-Saharan Africa: when care is free, trusted, and close to home, an AIDS-free generation moves within reach.